Since the beginning of the COVID-19 pandemic, activity in Hospital services has been altered. In the case of Urology Units, they have had to adapt to the new context without being guidelines for action to follow. The Spanish Archives of Urology magazine has published the monograph “Recommendations for action in a covid-19 pandemic ”in order […]
Research carried out by professors David Cantarero, Marta Pascual and Javier Lera (members of the R + D + i Group in Health Economics and Management of Health Services UC-IDIVAL) shows the great importance of the lifestyles of our greater in their use of health resources such as consultations and hospitalizations. In general, from the […]
The IDIVAL-UC and CIBER-BBN Photonic Engineering Research Group has demonstrated a fiber optic laser light source that, when integrated into a suitable microscope, allows CARS (Coherent Anti-Stokes Raman Scattering Microscopy) spectroscopy to be performed. that enables a new way of doing “photonic biopsies” in quasi-real time both in the laboratory and in clinical events. The […]
The IDIVAL-UC and CIBER-BBN Photonic Engineering Research Group has demonstrated a fiber optic laser light source that, when integrated into a suitable microscope, allows CARS (Coherent Anti-Stokes Raman Scattering Microscopy) spectroscopy to be performed. that enables a new way of doing “photonic biopsies” in quasi-real time both in the laboratory and in clinical events. The […]
Researchers from the Marqués de Valdecilla University Hospital and the Marqués Valdecilla Research Institute Foundation (IDIVAL) have collaborated in a study studying the GalNAC-MCJ molecule as a promising therapeutic agent for patients with fatty liver and advanced stages of disease. This international project is led by CIC bioGUNE Liver Disease by Dr. Malu Martínez Chantar […]
Researchers from the IDIVAL neurodegenerative diseases group and the CSUR group of HUMV hereditary ataxias and paraplegia, led by Dr. Jon Infante, have participated in an international multicenter study designed to identify preclinical and progression biomarkers in the most frequent form of autosomal dominant cerebellar ataxia, SCA3. The identification of accurate, reliable and easily accessible […]
IDIVAL obtains the official reaccreditation of the Carlos III Health Institute (ISCIII) as a Health Research Institute. A fundamental certification for the exercise of its competences in such fundamental areas as organ and tissue transplants or new therapies, neuroscience, cancer, infectious diseases and the immune system or diseases related to aging and life habits, in […]
IDIVAL obtains financing for two of the three projects presented in the Call for Challenges – Collaboration according to the proposal for a provisional resolution to grant aid to the call for early processing of 2019 for R + D + i projects “Challenges – Collaboration” of the Program State Research, Development and Innovation Oriented […]
The PAFIP group (Initial Psychosis Care Program) that is part of the IDIVAL Psychiatry group has published in the International Journal of Neuropsychopharmacology the article “Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone” in which six of the most widely used antipsychotics […]
The article “Cancer Patients and Anxiety: A Gender Perspective” published in the “International Journal of Environmental Research and Public Health” is part of a study that received first prize in the 16th edition of the National Nursing Prize of the Hospital Universitario Marqués de Valdecilla with the title “Progressive muscle relaxation technique in the care […]
